Gideon Adamu Shallangwa

Prof. Gideon Adamu Shallangwa

Department of Chemistry, Ahmadu Bello University, Zaria, Kaduna, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Heliyon
Verified
Journal Article
Open access
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
In-silico activity prediction was performed to predict new inhibitory activities of 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as anti-proliferative agents using QSAR technique. The anti-proliferative agents were optimized using Density Functional Theory (DFT) method utilizing the B3LYP/6-31G* level of theory. Genetic Function Algorithm (GFA) was used to build the QSAR models. Out of the models built, the best one was selected and reported because of its fitness statistically with the following assessment parameters: R2 trng = 0.919035, R2 adj = 0.893733, Q2 cv = 0.866475, R2 test = 0.636217, and LOF = 0.215884. The selected model was further subjected to other assessment such as VIF, Y-scrambling test, applicability domain and found to be statistically significant. The binding mode of some selected 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine (ligands) in the active site of EGFR-tyrosine kinase (EGFR-TK) (receptor) was studied via Molecular docking. Molecule 22 was identified to have the highest binding energy (-10.4 kcal/mol) among the other selected ligands which it might be as a result of hydrogen interactions formed with MET793 (2.48599 Å, 2.04522 Å) & THR854 (3.76616 Å) amino acid residues and hydrophobic/other interactions with amino acid residues (LEU718, LEU844, MET766, VAL726, ALA743, LYS745 and MET790) in the active site of EGFR-tyrosine kinase (EGFR-TK). The drug-likeness of these selected anti-proliferative agents were predicted via the pharmacokinetics profile of the molecules utilizing SWISS ADME. The anti-proliferative agents were found to be orally safe by not having more than 1 violation of the Lipinski's rule of five. This research proposed a way for designing potent anti-proliferative agents against their target enzyme.

8 November 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
FUFabian Ugbe
Fabian Ugbe
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
AUAdamu Uzairu
Adamu Uzairu
IAIbrahim Abdulkadir
Ibrahim Abdulkadir
EEEmmanuel Israel Edache
Emmanuel Israel Edache
Mohnad AbdallaMohnad Abdalla
Mohnad Abdalla
Leishmaniasis affects more than 12 million humans globally and a further 1 billion people are at risk in leishmaniasis endemic areas. The lack of a vaccine for leishmaniasis coupled with the limitations of existing anti-leishmanial therapies prompted this study. Cheminformatic techniques are widely used in screening large libraries of compounds, studying protein-ligand interactions, analysing pharmacokinetic properties, and designing new drug molecules with great speed, accuracy, and precision. This study was undertaken to evaluate the anti-leishmanial potential of some organoselenium compounds by quantitative structure-activity relationship (QSAR) modeling, molecular docking, pharmacokinetic analysis, and molecular dynamic (MD) simulation. The built QSAR model was validated (R2train = 0.8646, R2test = 0.8864, Q2 = 0.5773) and the predicted inhibitory activity (pIC50) values of the newly designed compounds were higher than that of the template (Compound 6). The new analogues (6a, 6b, and 6c) showed good binding interactions with the target protein (Pyridoxal kinase, PdxK) while also presenting excellent drug-likeness and pharmacokinetic profiles. The results of density functional theory, MD simulation, and molecular mechanics generalized Born surface area (MM/GBSA) analyses suggest the favourability and stability of protein-ligand interactions of the new analogues with PdxK, comparing favourably well with the reference drug (Pentamidine). Conclusively, the newly designed compounds could be synthesized and tested experimentally as potential anti-leishmanial drug molecules.Communicated by Ramaswamy H. Sarma.

5 July 2021 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
ZIZakari Ya'u Ibrahim
Zakari Ya'u Ibrahim
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SAStephen Eyije Abechi
Stephen Eyije Abechi
Background: The sixteen (16) designed data set of substituted aryl amine-based triazolopyrimidine were docked against Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) employing Molegro Virtual Docker (MVD) software and their pharmacokinetic property determined through SwissADME predictor. Results: The docking studies shows compound D16, 5-((6-methoxy-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino)benzo[b]thiophen-4-ol to be the most interactive and stable derivative (re-rank score = − 114.205 kcal/mol) resulting from the hydrophobic as well as hydrogen interactions. The hydrogen interaction produced one hydrogen bond with the active residues LEU359 (H∙∙H∙∙O) at a bond distances of 2.2874 Å. All the designed derivatives were found to pass the Lipinski rule of five tests, supporting the drug-likeliness of the designed compounds. Conclusion: The ADME analysis revealed a perfect concurrence with the Lipinski Ro5, where the derivatives were found to possess good pharmacokinetic properties such as molar refractivity (MR), number of rotatable bonds (nRotb), log of skin permeability (log Kp), blood-brain barrier (BBB). These results could a deciding factor for the optimization of novel antimalarial compounds.

4 April 2020 in SN Applied Sciences
Verified
Journal Article
Open access
PDF file
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
SK-MEL-5 is a human melanoma cell line that has been used in several researches to explore new therapies against melanoma. Based on this study we report on the development of quantitative structure–activity relationship (QSAR) model and molecular docking simulation able to predict the cytotoxic effect of diverse chemical compounds on this cancer cell line. The dataset of seventy-two (72) cytotoxic compounds were downloaded from the National Cancer Institute database. It contains the data of compounds for which cytotoxicity results expressed by pGI50 was recorded. The QSAR model was built using fifty (50) compounds and the best-generated model based on multiple linear regression showed, respectively good quality of fits [\(R^{2}\) (0.864), \(R_{adjusted}^{2}\) (0.846), Q2cv (0.841) and \(R_{pred}^{2}\) (0.885)]. The model’s predictive ability was determined by a test set of twenty-two (22) compounds and the applicability domain was assessed through leveraged approach. Compounds 41 and 69 were selected as templates for in silico design because they had high pGI50 activity and are within the model’s applicability domain. The obtained information from the model was explored to design novel compounds by introducing various substituents. Moreover, the designed compounds were docked into the active site of the protein (PDB CODE: 3OG7) which is responsible for melanoma cancer to elucidate their binding mode. Ia (− 12.4 kcal mol−1) and IIb (− 12.3 kcal mol−1) showed a better binding affinity for the target when compared with (vemurafenib, − 11.3 kcal mol−1) the known inhibitor of the target (V600E-BRAF). These results may be of great help in early anticancer drug discovery.

1 March 2020 in Heliyon
Verified
Journal Article
Open access
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
A dataset of seventy-two (72) cytotoxic compounds of the National Cancer Institute (NCI) was studied by QSAR and docking approaches to gain deeper insights into ligands selectivity on SK-MEL-2 cell line. The QSAR model was built using fifty (50) molecules and the best-generated model based on multiple linear regression showed, respectively good quality of fits ( R 2 (0.864), R a d j u s t e d 2 (0.845), Q2 cv (0.799) and R p r e d 2 (0.706)). The model's predictive ability was determined by a test set of twenty-two (22) compounds. Compounds 30 and 41 were selected as templates for in silico design because they had high pGI50 activity and are in the model's applicability domain. The obtained information from the model was explored to design novel molecules by introducing various modifications. Moreover, the designed compounds with better-predicted activity (pGI50) values were selected and docked on the active site of the protein (PDB-CODE: 3OG7) which is responsible for melanoma cancer to elucidate their binding mode. AN2 (-12.1kcalmol-1) and AC4 (-12.4kcalmol-1) showed a better binding score for the target when compared with (vemurafenib, -11.3kcalmol-1) the known inhibitor of the target (V600E-BRAF). These findings may be very helpful in early anti-cancer drug development.

22 January 2020 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
MAMustapha Abdullahi
Mustapha Abdullahi
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
AUAdamu Uzairu
Adamu Uzairu
Background: This research provides a comprehensive analysis of QSAR modeling performed on 25 aryl sulfonamide derivatives to predict their effective concentration (EC50) against H5N1 influenza A virus by using some numerical information derived from structural and chemical features (descriptors) of the compounds to generate a statistically significant model. Subsequently, the molecular docking simulations were done so as to determine the binding modes of some potent ligands in the dataset with the M2 proton channel protein of the H5N1 influenza A virus as the target. Results: In building the QSAR model, the genetic algorithm task was employed in the variable selection of the descriptors which are used to form the multi-linear regression equation. The model with descriptors, RDF100m, nO, and RDF45p, showed satisfactory internal and external validation parameters (R2train = 0.72963, R2adjusted = 0.67169, Q2cv = 0.598, $$ {R}_{\mathrm{pred}}^2= $$Rpred2= 0.67295, R2test = 0.6860) which passed the model criteria of acceptability. Docking simulation results of the more potent compounds (ligands 2, 3, and 8) revealed the formation of hydrophobic and hydrogen bonds with the binding pockets of M2 protein of influenza A virus. Conclusion: The results in this study can help to advance the research in designing (in silico design) and synthesis of more potent aryl sulfonamides derivatives against H5N1 influenza virus.